Highsun Holdings to acquire Fibrant's caprolactam business from DSM and CVC

Fibrant Holding BV announced the proposed sale of Fibrant BV and 60% of Fibrant China to Highsun Holdings Group Ltd. DSM, which indirectly owns 35% of Fibrant BV, expects to receive about €200 million from the transaction, expected to close in Q3 2018.

“It is estimated that DSM will receive about €200 million in cash following the closing of the transaction with Highsun Holdings Group Ltd.”prnewswire.com

• 1 source
• prnewswire.comDSM Informs Market on the Announced Sale of Fibrant's Caprolactam Business to HighsunRoyal DSMMay 17, 2018

Summarized from public sources; check the original articles before acting on it.